The association with CB1 endocannabinoid receptors suggested that the CB1 receptor may help mitigate morphological alterations by maintaining neurovascular health and reducing the neuroinflammatory response in depression (Dudek et al. 2025), which was consistent with previous research (Xue et al. 2025). Here, CNR1 is linked to major depressive disorder.